Related Experiment Video
Updated: Jan 10, 2026

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
Published on: May 16, 2025
Advances in Pseudomonas aeruginosa-Induced Programmed Cell Death and Potential Targeted Treatment Strategies
Chunjiang Tan1,2, Yifeng Luo1,2,3
1Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Abstract:
Pseudomonas aeruginosa (P. aeruginosa) is responsible for the high prevalence of various nosocomial infections, and it is challenging to completely eradicate P. aeruginosa infection in clinics. One of P. aeruginosa's main pathogenic mechanisms is to trigger multiple forms of programmed cell death (PCD), such as apoptosis, pyroptosis, necroptosis, ferroptosis, and PANoptosis, among which PANoptosis is a newly discovered PCD pathway mediated by PANoptosome complexes and their key upstream regulators. Compared with other well-studied PCD pathways, advances in P. aeruginosa-induced PANoptosis have yet to be thoroughly reviewed. This review highlights research advances in this pathway, providing mechanistic insights by summarizing the upregulation and/or activation of PANoptosome sensor proteins and their key upstream regulators during P. aeruginosa infection. We also offer perspectives on the mechanistic links between P. aeruginosa cytotoxicity and other forms of PCD. Additionally, pharmacological compounds that may be used to target P. aeruginosa-induced PCD, particularly PANoptosis, are discussed, and future research and therapeutic directions are proposed. Our work helps bridge the knowledge gap, paving the way for further understanding of P. aeruginosa-induced PCD and the development of novel therapeutics against P. aeruginosa infection.
Insights
Pseudomonas aeruginosa infections trigger programmed cell death (PCD) pathways, including PANoptosis. This review details advances in understanding P. aeruginosa-induced PANoptosis and proposes new therapeutic strategies.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- Pseudomonas aeruginosa (P. aeruginosa) causes significant nosocomial infections.
- P. aeruginosa employs programmed cell death (PCD) pathways, including apoptosis, pyroptosis, necroptosis, ferroptosis, and PANoptosis, as a pathogenic mechanism.
- PANoptosis, a newly identified PCD pathway, is mediated by PANoptosome complexes and their regulators.
Purpose of the Study:
- To review recent advances in P. aeruginosa-induced PANoptosis.
- To provide mechanistic insights into PANoptosome sensor protein activation during P. aeruginosa infection.
- To explore potential therapeutic targets for P. aeruginosa-induced PCD.
Main Methods:
- Literature review focusing on P. aeruginosa-induced programmed cell death.
- Analysis of mechanistic insights into PANoptosome activation.
- Discussion of pharmacological compounds targeting P. aeruginosa-induced PCD.
Main Results:
- Summarizes upregulation and activation of PANoptosome sensor proteins and regulators in P. aeruginosa infection.
- Highlights mechanistic links between P. aeruginosa cytotoxicity and various PCD forms.
- Identifies potential pharmacological agents for targeting P. aeruginosa-induced PANoptosis.
Conclusions:
- Advances in understanding P. aeruginosa-induced PANoptosis are crucial for combating infections.
- Targeting P. aeruginosa-induced PCD, especially PANoptosis, offers novel therapeutic avenues.
- Further research is needed to develop effective therapeutics against P. aeruginosa.
More Related Videos
07:27Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
08:34Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection
Published on: January 8, 2020
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Targeted Cancer Therapies
There are several types of targeted therapies against...